« News

Linnea appoints Susanne Caspar CEO

We are pleased to announce that Susanne Caspar has been appointed Chief Executive Officer of Linnea.

With more than 28 years of experience in the pharmaceutical industry, thereof more than 23 years in leading positions, Susanne worked for international companies as Whitehall Much (now Pfizer) and the German Merck. For family owned companies like Steiner Arzneimittel she held the position of Generai Manager and of CEO for Schaper & Bruemmer. Susanne brings her impressive background in sales, marketing and management to  Linnea, and we are sure that  her  guidance  will lead the company down a path of continued success.

“Linnea is an innovative, forward-looking partner to well-known brands in the pharmaceutical and healthcare industries. lts high-quality plant extracts – manufactured in Switzerland – are in demand internationally. I am delighted to accept the role of CEO and lead the team as we reach new milestones together.”


Linnea improves the quality of life by manufacturing and distributing worldwide APls and herbal extracts.Since 1982, the Swiss company has been proudly producing the finest quality purified and semi-synthetic APls and standardized herbal extracts. We are committed to providing gold-standard ingredients for use in the pharmaceutical, cosmetics and natural food industries.

Quality defines every step of our production process, from picking and processing to selling and shipping. Carefully selected plantations supply excellent raw materials. Our GMP-certified facility, working 24 hours a day and seven days a week, transforms the raw materials into finished products while strictly abiding by all regulations. Our team of experienced professionals is also focused on researching cutting-edge solutions and new technologies  to ensure  that  our extracts and APls are continually improving. This is Linnea – a trusted, responsible manufacturer of exceptional  natural ingredients, today just as decades ago.